Novartis Investigative Site — Falls Church, Virginia

Novartis Investigative Site is a clinical research site located in Falls Church, Virginia, United States 22043.

Crixeo Clinical Trials Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Novartis Investigative Site has participated in 9 clinical trials with 1 currently active.

Therapeutic areas: Relapsing Multiple Sclerosis, Acute Heart Failure, Cardiovascular Disease and Lipoprotein(a).

Sponsors: Novartis Pharmaceuticals, Mereo BioPharma.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Novartis Investigative Site?

Novartis Investigative Site has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Novartis Investigative Site conducted?

Novartis Investigative Site has 9 clinical trials on record, with 1 currently active. Their work covers Relapsing Multiple Sclerosis, Acute Heart Failure, Cardiovascular Disease and Lipoprotein(a).

Is Novartis Investigative Site accredited by Crixeo Clinical Trials?

Novartis Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Novartis Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.